@article{tamargo:hal-01143095,
TITLE = {Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide},
AUTHOR = {Tamargo, Juan and Le Heuzey, Jean-Yves and Mabo, Phillipe},
URL = {https://univ-rennes.hal.science/hal-01143095},
NOTE = {Conflict of interestJT has received honoraria/consultancy fees from Menarini and Servier. JYLH has received consultancy fees and/or attended conferences and advisory boards for Astra-Zeneca, Bayer, BMS/Pfizer, Boehringer-Ingelheim, Correvio,Daiichi-Sankyo, Meda and Servier. PM has received honoraria/consultancy fees from Meda France Ltd.},
JOURNAL = {European Journal of Clinical Pharmacology},
PUBLISHER = {Springer Verlag},
VOLUME = {71},
NUMBER = {5},
PAGES = {549--567},
YEAR = {2015},
MONTH = May, DOI = {10.1007/s00228-015-1832-0},
KEYWORDS = {Generic drugs ; Flecainide ; Antiarrhythmic drugs ; Bioequivalence ; Narrow therapeutic index ; Safety},
PDF = {https://univ-rennes.hal.science/hal-01143095/file/Narrow%20therapeutic%20index%20drugs.pdf},
HAL_ID = {hal-01143095},
HAL_VERSION = {v1},
}